Alcon AG
ALC86.480USD
+0.450+0.52%
Close 08/13, 16:00（ET）Quotes delayed by 15 min
42.77BMarket Cap
38.19P/E TTM
More Details of Alcon AG Company
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Company Info
Ticker SymbolALC
Company nameAlcon AG
IPO dateApr 09, 2019
CEOMr. David J. Endicott
Number of employees25599
Security typeOrdinary Share
Fiscal year-endApr 09
AddressRue Louis d'Affry 6
CityFRIBOURG
Stock exchangeSIX Swiss Exchange
CountrySwitzerland
Postal code1700
Phone41589113800
Websitehttps://www.alcon.ch/
Ticker SymbolALC
IPO dateApr 09, 2019
CEOMr. David J. Endicott
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Mr. Leon Sergio Duplan Fraustro
Mr. Leon Sergio Duplan Fraustro
Senior Vice President, President - Americas
Senior Vice President, President - Americas
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
By BusinessUSD
Name
Revenue
Proportion
Consumables
712.00M
29.05%
Contact lenses
688.00M
28.07%
Implantables
420.00M
17.14%
Equipment/other
199.00M
8.12%
By RegionUSD
Name
Revenue
Proportion
International
1.31B
53.61%
United States
1.14B
46.39%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
712.00M
29.05%
Contact lenses
688.00M
28.07%
Implantables
420.00M
17.14%
Equipment/other
199.00M
8.12%
Shareholding Stats
Updated: 6 hours ago
Updated: 6 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.13%
Aristotle Capital Management, LLC
2.45%
UBS Fund Management (Switzerland) AG
2.31%
Norges Bank Investment Management (NBIM)
2.27%
Other
83.90%
Shareholders
Shareholders
Proportion
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.13%
Aristotle Capital Management, LLC
2.45%
UBS Fund Management (Switzerland) AG
2.31%
Norges Bank Investment Management (NBIM)
2.27%
Other
83.90%
Shareholder Types
Shareholders
Proportion
Investment Advisor
29.05%
Investment Advisor/Hedge Fund
25.90%
Bank and Trust
4.47%
Sovereign Wealth Fund
2.61%
Hedge Fund
2.39%
Pension Fund
1.71%
Research Firm
1.63%
Individual Investor
0.13%
Insurance Company
0.10%
Other
32.02%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1631
340.08M
68.06%
-38.93M
2025Q1
1659
342.42M
68.52%
-42.21M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
2023Q1
1566
324.92M
65.02%
+2.70M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
19.86M
3.98%
+509.47K
+2.63%
Mar 31, 2025
Aristotle Capital Management, LLC
12.23M
2.45%
-607.09K
-4.73%
Mar 31, 2025
UBS Fund Management (Switzerland) AG
11.54M
2.31%
-398.72K
-3.34%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
12.62M
2.53%
+276.47K
+2.24%
Dec 31, 2024
Zürcher Kantonalbank (Asset Management)
8.51M
1.7%
-417.07K
-4.67%
Mar 31, 2025
AKO Capital LLP
7.12M
1.42%
+1.24M
+21.09%
Mar 31, 2025
Harding Loevner LP
7.12M
1.43%
-1.35M
-15.94%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
6.41M
1.28%
-8.66M
-57.46%
Mar 31, 2025
Select Equity Group, L.P.
5.48M
1.1%
-1.04M
-15.96%
Mar 31, 2025
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
Global X Aging Population ETF
2.86%
Franklin FTSE Switzerland ETF
2.73%
iShares MSCI Switzerland ETF
2.64%
Running Oak Efficient Growth ETF
1.97%
First Trust Indxx Medical Devices ETF
1.85%
BNY Mellon Women's Opportunities ETF
1.08%
Global X S&P Catholic Values Developed ex-US ETF
1.05%
First Trust Switzerland Alphadex Fund
0.93%
iShares Global Healthcare ETF
0.63%
Wahed Dow Jones Islamic World ETF
0.59%
View more
Global X Aging Population ETF
Proportion2.86%
Franklin FTSE Switzerland ETF
Proportion2.73%
iShares MSCI Switzerland ETF
Proportion2.64%
Running Oak Efficient Growth ETF
Proportion1.97%
First Trust Indxx Medical Devices ETF
Proportion1.85%
BNY Mellon Women's Opportunities ETF
Proportion1.08%
Global X S&P Catholic Values Developed ex-US ETF
Proportion1.05%
First Trust Switzerland Alphadex Fund
Proportion0.93%
iShares Global Healthcare ETF
Proportion0.63%
Wahed Dow Jones Islamic World ETF
Proportion0.59%
Dividend
A total of
400.00M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
